Results 211 to 220 of about 85,373 (307)

Interpretable CRAM‑Enhanced Lightweight Dual‑Branch CNN for Real‑Time Breast Cancer Histopathology in Internet‑of‑Medical‑Things Environments

open access: yesSmall, EarlyView.
This study presents an interpretable, lightweight hybrid deep learning model for real‐time analysis of breast cancer histopathology in IoMT‐enabled diagnostic systems. By integrating MobileNetV2 and EfficientNet‐B0 with a novel contextual recurrent attention module (CRAM), the framework achieves near‐perfect accuracy while providing transparent Grad ...
Roseline Oluwaseun Ogundokun   +4 more
wiley   +1 more source

Polyhedral Oligomeric Silsesquioxane Based Material for Tumor Heterogeneity MR Visualization and Precise Treatment

open access: yesSusMat, EarlyView.
ABSTRACT Malignant tumors whose mortality rates up to 97% possess high heterogeneity that leads to rapid growth, strong invasive capability, and low drug sensitivity. Quantitative magnetic resonance imaging enables direct visualization of tumors. However, gadolinium‐based contrast agents used in clinical practice have significant drawbacks of short ...
Xiaochuan Geng   +13 more
wiley   +1 more source

Constructing Difference: Maternal Boundary‐Work in Science‐Based and Natural Mom Groups on Facebook

open access: yesSymbolic Interaction, EarlyView.
Boundary‐work describes the activities of social groups as they seek to differentiate themselves from others to establish credibility, authority, or to protect their interests. While a growing body of literature explores occupational boundary‐work in health care, limited research has focused on how lay actors practice boundary‐work online.
Darryn DiFrancesco
wiley   +1 more source

Towards the Development of a Conceptual Framework of the Determinants of Pre‐eclampsia: A Hierarchical Systematic Review of Biomarkers

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Pre‐eclampsia is a leading cause of maternal and perinatal morbidity and mortality. There are several determinants of individual pregnant women's risk of developing pre‐eclampsia, including biomarkers and ultrasound markers. Objective A conceptual framework to collate and summarise the extensive body of literature on biomarkers ...
Terteel Elawad   +89 more
wiley   +1 more source

Induced abortion, miscarriage, and the risk of breast cancer—A registry‐based study from Finland

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
The history of induced abortion or miscarriage is not associated with an increased risk of either pre‐ or postmenopausal breast cancer. Abstract Introduction The potential effect of induced abortion and miscarriage on the risk of breast cancer has remained debated and has been a persistent source of misinformation. Many previous studies have been small
Sushmita Katuwal   +4 more
wiley   +1 more source

Breast cancer in northern Peru: molecular subtypes and HER2 low. [PDF]

open access: yesRev Peru Med Exp Salud Publica
Gómez-Rázuri K   +3 more
europepmc   +1 more source

Desarrollo de nanopartículas mesoporosas de sílice para el tratamiento de cancer de mama

open access: yes, 2016
[EN] The aim of this project is to develop nanodispositives based on silica mesoporous nanoparticles for triple negative breast cancer treatment. Those will be directed against the cancer stem cell subpopulation for controlled delivery of a cytotoxic drug and microRNAs involved in drug resistance.
openaire   +2 more sources

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
It is expected that the relugolix estetrol combination RE4W will enable women to control their fertility and prevent menstrual cycle related problems, while offering a smooth transition through perimenopause into the postmenopause and decrease the risk of breast cancer.
Herjan J. T. Coelingh Bennink   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy